-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Translational Geroscience Biomarkers in Hematologic Malignancies

Symposia: Scientific Workshop on Aging and Hematology Program: Scientific Workshops
Friday, December 6, 2024: 4:15 PM-4:57 PM
Room 7 (San Diego Convention Center)
Moderators:
Andrew Artz, MD, MS, City of Hope National Medical Center and Mazie Tsang, MD, Mayo Clinic
Disclosures:
Tsang: AstraZeneca: Other: Advisory Board; Poseida Therapeutics: Current holder of stock options in a privately-held company; AVEO: Other: Prior holder of stock options in a privately-held company; Novartis: Other: Advisory Board; Genentech: Other: Advisory Board.
In this session we will discuss biomarkers associated with aging-related processes in individuals diagnosed with hematologic malignancies, and how these biomarkers compare to chronological aging in bench to bedside translational research.
Moderator Introduction and Session 4 Initial Audience Voting

Andrew Artz, MD, MS

City of Hope National Medical Center, Duarte, CA
Biomarkers of Aging: Chasing the Holy Grail in Hematologic Malignancies?

Ashley Rosko, MD

The Ohio State University, Columbus, OH
Clinical Frailty Assessments and Biomarkers of Biological Aging

Nadine Abdallah, MD

Mayo Clinic, Rochester, MN
Promising Biomarkers of Premature Cognitive Aging in Survivors of Adolescent and Young Adult Hodgkin Lymphoma

Annalynn M Williams, PhD, MS

James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY
Panel Discussion
See more of: Scientific Workshop on Aging and Hematology
See more of: Scientific Workshops
<< Previous Session | Next Session >>